Ladenburg Thalmann initiated coverage on Biodexa Pharmaceuticals PLC with a new price target
$BDRX
Biotechnology: Pharmaceutical Preparations
Health Care
Ladenburg Thalmann initiated coverage of Biodexa Pharmaceuticals PLC with a rating of Buy and set a new price target of $8.00